Abiomed, Inc. (ABMD) CEO Michael Minogue on Q4 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/28/22
Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over YearBusiness Wire • 04/28/22
World's First Patient Implanted with Impella BTR Minimally Invasive Heart PumpBusiness Wire • 04/26/22
NACD New England Honors Boston Scientific, A.D. Makepeace, Rapid7 CEO Corey Thomas, Bennie Wiley, and Jack F.Business Wire • 04/21/22
Abiomed to Host Investor Call on Impella ECP, the World's Smallest Heart Pump at 9 FrenchBusiness Wire • 03/21/22
Abiomed to Present at the SVB Leerink 11th Annual Global Healthcare ConferenceBusiness Wire • 02/08/22
Abiomed Inc. (ABMD) CEO Mike Minogue on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 02/04/22
Analysts Estimate Abiomed (ABMD) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 01/27/22
Early Feasibility Study Demonstrates Successful Use of Abiomed's preCARDIA TechnologyBusiness Wire • 01/12/22
Regulators Approve Impella 5.5 With SmartAssist in Japan and Hong Kong; US FDA Grants Impella BTR Conditional IDE Approval for First-in-Human Early Feasibility StudyBusiness Wire • 01/10/22